Document |
Document Title |
WO/2022/101282A1 |
The present invention relates to methods using recombinant Thauera aromatica cells to produce oxygen-independent molybdenum-hydroxylases in order to convert vitamin D3, 7-dehydrocholesterol and related alkylated compounds into 25-hydroxy...
|
WO/2022/099837A1 |
Provided is a Pseudomonas syringae pv. Actinidiae phage (PSA-P1) with a deposit number of CCTCC NO: M 2020252. The phage has high resistance to ultraviolet light and pH. Within the titer range of 101 PFU/mL-108 PFU/mL, the PSA-P1 has an ...
|
WO/2022/099427A1 |
Disclosed are: a freeze-dried bacterial consortium comprising a strain of Acinetobacter sp., a strain of Serratia sp. and a strain of Bacillus sp.; a method for preparing same; and a use and method applying same, to inhibit the developme...
|
WO/2022/103103A1 |
Provided are: a novel lipid peptide compound, and a stereoisomer, a solvate, or a pharmaceutically acceptable salt thereof; a method for producing same; and an anticancer use thereof. The lipid peptide compound, and a stereoisomer, a sol...
|
WO/2022/100127A1 |
Provided is an application of Lactobacillus paracasei K56 in the preparation of a composition resisting aging, improving innate immunity of organisms, and/or increasing the resistance of organisms to Stapyhlococcus aureus infections. Lac...
|
WO/2022/100632A1 |
Lacticaseibacillus rhamnosus for preventing and/or treating diseases caused by the reproductive tract flora disorder and/or bone loss and an application thereof. The Lacticaseibacillus rhamnosus is OF44-15Ph10T, and the accession number ...
|
WO/2022/100746A1 |
The present invention provides a bispecific single-chain antibody BiTEs-PD-L1 capable of simultaneously binding to CD3 and PD-L1 on the surface of a tumor cell, an antibody-loaded recombinant oncolytic virus, and a virus combination. Whe...
|
WO/2022/103318A1 |
A genetically modified yeast cell, wherein the yeast cell comprises a genetic modification comprising overexpression of yeast gene encoding porphobilinogen deaminase (HEM3), the HEM3 gene having at least 80 % identity with SEQ ID No. 7. ...
|
WO/2022/095684A1 |
Provided are a recombinant microorganism modified by means of genetic engineering and an application of the recombinant microorganism in production of tagatose, a preparation method for the recombinant microorganism, a tagatose productio...
|
WO/2022/094847A1 |
A cell lysis solution of an engineering bacterium, particularly a cell lysis solution of a facultative anaerobic bacterium that knocks out the dapA gene or the dapE gene, and the use thereof in tumor therapy.
|
WO/2022/098133A1 |
The present invention relates to a Streptomyces sp. strain having an antiviral efficacy and an antiviral composition including same.
|
WO/2022/094864A1 |
Provided are a method for constructing strictly anaerobic salmonella, the strictly anaerobic salmonella constructed using the method, and an application thereof in tumor treatment.
|
WO/2022/098124A1 |
The present invention relates to a novel Lactobacillus sp. strain and various uses of extracellular vesicles derived from the strain, and may provide novel Lactobacillus kefirgranum and extracellular vesicles derived therefrom. The prese...
|
WO/2022/098689A1 |
Provided herein are compositions and methods for screening pesticides. In particular, provided herein are Bt resistant corn earworms, methods of generating such earworms, and the use of such earworms in screening applications.
|
WO/2022/094865A1 |
Provided are a genetically engineered bacterium and a preparation method therefor. The genetically engineered bacterium is a salmonella strain that has knocked out dapA or dapE gene. Also provided is an application of the strain in tumor...
|
WO/2022/095127A1 |
Provided are a biocontrol strain YW-1, preparation of a biocontrol agent using the biocontrol strain YW-1, and an application of the biocontrol agent. The accession number of the strain is CGMCC NO. 20620; the biocontrol strain can effec...
|
WO/2022/094867A1 |
Provided are a PP2 gene sequence of an anaerobic activation promoter, an anaerobic gene loop regulated by a PP2 promoter, obligate anaerobic Salmonella typhimurium containing the anaerobic gene loop regulated by the PP2 promoter, a vecto...
|
WO/2022/097152A1 |
The present invention provides bacteria bio-stimulant compositions and methods for stimulating herbicide-degrading bacteria and promoting the degradation of herbicides in soil.
|
WO/2022/095731A1 |
Disclosed are a kit and a method for detecting SARS-CoV-2. By means of combining a One step RT-PCR with a Taqman probe method in the kit of the present invention, the ORF1ab gene and N gene-specific region, and optionally a non-human end...
|
WO/2022/095295A1 |
Provided are a new Bacillus strain HSY204, and insecticidal genes and the use thereof. The new Bacillus strain HSY204 is classified and named Bacillus cereus HSY204, and comprises three new insecticidal genes. A bioactivity assay shows t...
|
WO/2022/095290A1 |
Disclosed are Bacillus SJ110, an insecticidal protein, a vip3-like insecticidal gene and the use thereof. The Bacillus SJ110 belongs to Bacillus toyonensis, and is deposited at the China Center for Type Culture Collection with a deposit ...
|
WO/2022/088205A1 |
A method for producing a bacterial fertilizer by propagating Trichoderma, comprising: inoculating a Trichoderma strain into a PDA culture medium and cultivating for 3-6 days, so as to obtain a Trichoderma species; taking, in parts by wei...
|
WO/2022/090595A1 |
The present invention relates to a microorganism of the genus Bifidobacterium spp. comprising a promoter comprising the sequence GAAAGGA (SEQ ID NO: 1) at a distance of between 12 and 31 nucleotides from the start codon responsible for t...
|
WO/2022/092919A1 |
The present invention relates to novel bifidobacterium longum strain z1 and a composition comprising same, the strain being useful for prevention or treatment of irritable bowel syndromes (IBSs), inflammatory bowel diseases (IBDs), liver...
|
WO/2022/088770A1 |
Provided is an application of an anthrax fatty acid hydroxylase CsSCS7 in regulating fungal degradation of a pyrrole medicament. Also provided is a method for constructing a gene knockout vector and a gene knockout mutant of the anthrax ...
|
WO/2022/088483A1 |
A Bacillus sp. NB-1, and a culture method therefor and the use thereof. The Bacillus sp. has a deposit number of CCTCC NO: M 2020304, and can significantly reduce ammonia nitrogen and nitrite in aquaculture water and aquaculture tail water.
|
WO/2022/092783A1 |
The present invention relates to: the application of a Prevotella stercorea strain for cancer prevention or treatment; and the like. The inventors identified that a Prevotella stercorea strain increases the proliferation of T cells and i...
|
WO/2022/093785A1 |
The present disclosure provides in vitro methods for producing cotton fiber, including methods using cotton varietals the were discovered to be particularly amendable for use in the presently disclosed in vitro methods of cotton fiber pr...
|
WO/2022/092864A1 |
The present invention relates to microorganisms with reduced mucilage production ability, a method for producing fermented soy product using same, fermented soy product produced thereby, and uses thereof.
|
WO/2022/087856A1 |
An antigen presenting system of a novel coronavirus vaccine using attenuated salmonella for secreting and expressing an RBD domain protein, and the use thereof. The antigen presentation system is used for preventing novel coronavirus (SA...
|
WO/2022/088263A1 |
Disclosed are recombinant Escherichia coli for efficient production of succinic acid and a construction method for the recombinant Escherichia coli. The method comprises: knocking out a by-product encoding gene of a succinic acid produci...
|
WO/2022/088482A1 |
Provided are pseudomonas putida DB-1, a culture method therefor and an application thereof. The pseudomonas putida DB-1 is preserved in China Center for Type Culture Collection on July 14, 2020, in Wuhan University of Wuhan, China, and t...
|
WO/2022/087870A1 |
Rhizobium, named rhizobium sp. NPLJ-2, was deposited in the China Center for Type Culture Collection on October 19, 2020, with the deposit number of CCTCC M 2020603. Use of the rhizobium in degradation of nonylphenol in a water environme...
|
WO/2022/087854A1 |
A SARS-CoV-2 vaccine antigen presenting system of an NTD domain protein secreted and expressed by attenuated salmonella typhimurium, and the use thereof, which are used for preventing SARS-CoV-2. By means of constructing a controllable a...
|
WO/2022/083245A1 |
Provided are Bacillus altitudinis ST15 with preservation number CGMCC No.20156 for antagonizing Xanthomonas oryzae and use thereof. The ST15 strain has relatively high antagonistic activity against both Xanthomonas oryzae pv. oryzae and ...
|
WO/2022/083051A1 |
Provided is Sanguibacter sp.M0055, which is deposited in the China General Microbiological Culture Collection Center, and the deposit number is CGMCC 20597, and the deposit date is 4 September 2020. The Sanguibacter has a significant ant...
|
WO/2022/085819A1 |
The present invention relates to a composition for osteogenesis promotion comprising Enterococcus faecium L15 KCTC13498BP. The composition of the present invention can promote the induction of osteogenic differentiation of osteoblasts an...
|
WO/2022/086041A1 |
The present invention provides a novel Lactobacillus sp. strain and a use thereof. The Lactobacillus sp. strain has high antibacterial activity against various pathogenic bacteria such as fish-pathogenic bacteria and dental caries bacter...
|
WO/2022/082362A1 |
A non-pathogenic bacterial gene expression system and a transformant for metabolizing tyrosine, a use thereof for preparing a composition for reducing urinary toxins, and a method for metabolizing tyrosine using same. The gene expression...
|
WO/2022/085938A1 |
The present invention relates to a Planococcus sp. strain having astaxanthin secreting ability, and uses thereof. In the present invention, a novel microorganism secreting astaxanthin has been identified from a Planococcus sp. strain sec...
|
WO/2022/083007A1 |
Provided are a fermentation method for producing high-content Bacillus coagulans spore probiotics by means of using cocoa powder and the use thereof. By means of adding an appropriate amount of cocoa powder to Bacillus coagulans for soli...
|
WO/2022/084978A1 |
The present disclosure relates to a process for preparation of a peptide of sequence ID No. 1 having a formula C231H354N66O83 from an endophytic bacterium Paenibacillus peoriae IBSD35 isolated from the stem of Millettia pachycarpa. The g...
|
WO/2022/083516A1 |
Provided are a Serratia lipase with the effect of killing plasmodium, and a coding gene thereof. A fatty hydrolase is isolated from the Serratia and named AmLip. The AmLip polypeptide has a selective killing ability, and specifically enz...
|
WO/2022/086365A1 |
The invention relates to immunology. There is described the agent for inducing specific immunity against SARS-CoV-2, in liquid form, which contains a single active component, comprising the expression vector of human adenovirus serotype ...
|
WO/2022/086364A1 |
The invention relates to biotechnology, immunology and virology. There is described the agent for inducing specific immunity against SARS-CoV-2, in lyophilized (freeze-dried) form, which contains a single active component, comprising the...
|
WO/2022/077702A1 |
Provided are a DNA sequence for detecting 8 types of Bacillus cereus, and a DNA probe being ligated to magnetic microspheres labeled with different fluorescent dyes and comprising a DNA fragment selected from Bacillus cereus G6235, G6206...
|
WO/2022/078140A1 |
The present invention relates to the technical field of microorganisms, and provides an alginate lyase producing strain HB171785. The strain belongs to γ-proteobacteria genus Neiella, the accession number is GDMCC No.61001, and alginate...
|
WO/2022/080572A1 |
The present invention relates to an anti-radiation composition comprising one or more types of microorganisms selected from the group consisting of Cladosporium sp., Phanerochaete sp., and Trichosporon sp. , and to anti-radiation materia...
|
WO/2022/077908A1 |
Disclosed is an isoenergetic deformation composite foundation utilizing microorganisms to solidify an aggregate, and a construction method. The composite foundation comprises pile bodies and a cushion layer, wherein several pile bodies a...
|
WO/2022/078518A1 |
Disclosed is a modified IL-2 molecule, wherein the modification comprises replacing a region in an IL-2 molecule that mediates the binding of the IL-2 molecule to IL2Rα with a region in an IL-15 molecule that mediates the binding of the...
|